Suchergebnisse - "Härmark, Linda"

PubPharm (145)

31

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3

32

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3

33

Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand

enthalten in: Drug safety | 2020

von Barnes, J. | Sheridan, J. | Dong, C. | +3

34

Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand

enthalten in: Drug safety | 2020

von Barnes, J. | Sheridan, J. | Dong, C. | +3

35

Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand

enthalten in: Drug safety | 2020

von Barnes, J. | Sheridan, J. | Dong, C. | +3

36

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3

37

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3

38

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

enthalten in: Drug safety | 2020

von Härmark, L. | Weits, G. | Meijer, R. | +3

39

Insight in the safety profile of antidiabetic agents glucagon‐like peptide‐1 agonists and dipeptidyl peptidase‐4 inhibitors in daily practice from the patient perspective

enthalten in: Pharmacoepidemiology and Drug Safety | 2020

von Gorp, A. | Rolfes, L. | Härmark, L. | +3

40

Peesklachten bij gebruik van fluorochinolonen

enthalten in: Huisarts en wetenschap | 2019

von Härmark, L.